GE HealthCare Technologies (GEHC) to Release Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is expected to be posting its Q1 2026 results before the market opens on Wednesday, April 29th. Analysts expect GE HealthCare Technologies to post earnings of $1.07 per share and revenue of $5.0316 billion for the quarter. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Wednesday, April 29, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.45 EPS. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

GE HealthCare Technologies Stock Down 2.5%

Shares of GE HealthCare Technologies stock opened at $72.26 on Wednesday. The stock has a 50-day moving average price of $75.21 and a 200 day moving average price of $77.92. The company has a market cap of $32.97 billion, a P/E ratio of 15.85, a P/E/G ratio of 1.63 and a beta of 1.17. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies has a 1 year low of $60.75 and a 1 year high of $89.77.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on GEHC shares. Piper Sandler cut their price target on GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating for the company in a research note on Friday. Barclays raised their price target on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Friday, February 6th. Citigroup cut their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research note on Wednesday, March 11th. The Goldman Sachs Group cut their price target on GE HealthCare Technologies from $97.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Finally, Mizuho cut their price target on GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday, April 13th. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $89.77.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in GE HealthCare Technologies in the 4th quarter valued at about $533,655,000. Boston Partners bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $287,627,000. Dodge & Cox increased its position in GE HealthCare Technologies by 13.4% in the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares in the last quarter. Hotchkis & Wiley Capital Management LLC increased its position in GE HealthCare Technologies by 17.1% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock valued at $633,271,000 after buying an additional 1,232,828 shares in the last quarter. Finally, Alyeska Investment Group L.P. increased its position in GE HealthCare Technologies by 100.8% in the 4th quarter. Alyeska Investment Group L.P. now owns 2,177,563 shares of the company’s stock valued at $178,604,000 after buying an additional 1,093,012 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.